canigen sha2ppi/l ad us. vet. lyophilisat und suspension zur herstellung einer injektionssuspension für hunde
virbac (switzerland) ag - canine distemper virus (cdv), lederle strain, live attenuated, canine adenovirus type 2 (cav), manhattan strain, live attenuated, canine parvovirus (cpv), strain cpv780916, live attenuated, canine parainfluenza virus (cpiv), manhattan strain, live attenuated, leptospira (l.) canicola, inactivated, leptospira (l.) icterohaemorrhagiae, inactivated - lyophilisat und suspension zur herstellung einer injektionssuspension für hunde - praeparatio cryodesiccata: canine distemper virus (cdv), lederle strain, live attenuated 10^3.0-10^5.0 u., canine adenovirus type 2 (cav), manhattan strain, live attenuated 10^4.0-10^6.0 u., canine parvovirus (cpv), strain cpv780916, live attenuated 10^5.0-10^7.0 u., canine parainfluenza virus (cpiv), manhattan strain, live attenuated 10^5.0-10^7.0 u., gelatina, kalii hydroxidum, lactosum monohydricum, acidum glutamicum, kalii dihydrogenophosphas, dikalii phosphas anhydricus, natrii chloridum, dinatrii phosphas, aqua ad iniectabile, pro vitro, residui: gentamicinum. suspension: leptospira (l.) canicola, inactivated 4350 - 7330 u., leptospira (l.) icterohaemorrhagiae, inactivated 4250 - 6910 u., natrii hydroxidum, saccharum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, tryptone, aqua ad iniectabile, ad suspensionem pro 1 ml. - attenuierter lebendimpfstoff gegen staupe- adeno- parvo- und parainfluenzaviren und inaktivierter bakterieller impfstoff gegen leptospiren bei hunden - impfstoffe
respiporc flupan h1n1
ceva santé animale - influenza a virus/human strain: a/jena/vi5258/2009 (h1n1)pdm09, inactivated - immunologische, inaktivierte virale impfstoffe für schweine, schweine-influenzavirus - schweine - aktive immunisierung von schweinen ab einem alter von 8 wochen gegen pandemisches schweinegrippevirus h1n1 zur verringerung der viralen lungenlast und virusausscheidung. the vaccine can be used during pregnancy up to three weeks before expected farrowing and during lactation lactation.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - impfstoffe - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
parvoruvax ad us. vet. suspension injectable pour porcs
biokema s.a. - porcine parvovirus (ppv ), strain k22, inactivated, erysipelothrix (e.) rhusiopathiae (lysed), serotype 2, strain im 950 - suspension injectable pour porcs - porcine parvovirus (ppv ), strain k22, inactivated ≥ 2 u., erysipelothrix (e.) rhusiopathiae (lysed), serotype 2, strain im 950 ≥ 1 u., aluminii oxidum hydricum 4.2 mg, thiomersalum max. 0.2 mg, natrii chloridi solutio 9 g/l, ad suspensionem pro dosi 2 ml. - vaccin viral et bactérien inactivé contre le parvovirus porcin et l'erysipelothrix rhusiopathiae chez les porcs - impfstoffe
btvpur btv 4 ad us. vet. suspension injectable pour ovins et bovins
biokema s.a. - inactivated bluetongue virus, serotype 4 - suspension injectable pour ovins et bovins - inactivated bluetongue virus, serotype 4 1.86 log10 u., aluminii oxidum hydricum 2.7 mg, saponinum 30 u., ad suspensionem pro dosi 1 ml. - vaccin inactivé contre l’orbivirus bovin (maladie de la langue bleue) chez les bovins et ovins - impfstoffe
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza-virus-oberflächenantigene (hämagglutinin und neuraminidase) des stammes a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - impfstoffe - aktive immunisierung gegen den h5n1-subtyp des influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
duvaxyn ehv 1.4 ad us. vet. injektionssuspension für pferde
zoetis schweiz gmbh - equine herpesvirus type 1 (ehv1), strain 438/77, inactivated, equine herpesvirus type 4 (ehv4), strain 405/76, inactivated - injektionssuspension für pferde - equine herpesvirus type 1 (ehv1), strain 438/77, inactivated ≥ 1 u., equine herpesvirus type 4 (ehv4), strain 405/76, inactivated ≥ 1 u., carbomerum 934p 6 mg, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile, ad suspensionem pro dosi 1.5 ml. - inaktivierter impfstoff gegen das equine rhinopneumonitisvirus (herpesvirus) bei pferden - impfstoffe
insol trichophyton ad us. vet. injektionssuspension für rinder
boehringer ingelheim (schweiz) gmbh - trichophyton verrucosum (strain no. 410), inactivated, trichophyton mentagrophytes (strain no. 1032), inactivated, trichophyton sarkisovii (strain no. 551), inactivated - injektionssuspension für rinder - trichophyton verrucosum (strain no. 410), inactivated ≥ 17 mio. u., trichophyton mentagrophytes (strain no. 1032), inactivated ≥ 17 mio. u., trichophyton sarkisovii (strain no. 551), inactivated ≥ 17 mio. u., thiomersalum max. 0.04 mg, glucosum, carnis extractum, aqua, ad suspensionem pro 1 ml. - inaktivierter mykotischer impfstoff gegen trichophyton bei rindern - impfstoffe
purevax rc ad us. vet. lyophilisat und lösungsmittel zur herstellung eine injektionssuspension für katzen
boehringer ingelheim (schweiz) gmbh - feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated, feline calicivirus antigens (fcv), strains 431 and g1, inactivated - lyophilisat und lösungsmittel zur herstellung eine injektionssuspension für katzen - praeparatio cryodesiccata: feline rhinotracheitis virus (herpesvirus fhv), strain f2, live attenuated 10^4.9 - 10^6.2 u., feline calicivirus antigens (fcv), strains 431 and g1, inactivated 2.0 - 3.3 u., saccharum, sorbitolum, dextranum 40, caseinum hydrolysatum, collagenum hydrolysatum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, kalii hydroxidum, natrii chloridum, dinatrii phosphas, pro vitro, residui: gentamicinum. i) lösungsmittel 0.5 ml: aqua ad iniectabile, ad solutionem pro 0.5 ml. ii) lösungsmittel 1 ml: aqua ad iniectabile, ad solutionem pro 1 ml. - attenuierter lebendimpfstoff gegen felines rhinotracheitisvirus mit antigenen des inaktiverten felinen calicivirus bei katzen - impfstoffe
fixr parvo lepto emulsion zur injektion
kernfarm - das porcine parvovirus; leptospira interrogans australis; leptospira interrogans canicola; leptospira interrogans grippotyphosa; leptospira interrogans icterohaemorrhagiae; leptospira interrogans pomona; leptospira interrogans sejroe - emulsion zur injektion - das porcine parvovirus ; leptospira interrogans australis ; leptospira interrogans canicola ; leptospira interrogans grippotyphosa ; leptospira interrogans icterohaemorrhagiae ; leptospira interrogans pomona; leptospira interrogans sejroe - inactivated viral and inactivated bacterial vaccines - schwein